Evidence map›Paper›PMID 24140022›Full record

ReviewTrends in endocrinology and metabolism: TEM2014

Ketone bodies as signaling metabolites.

John C Newman, Eric Verdin

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02796950 (The Effect of Acipimox on GLP-1 Secretion in Healthy Subjects), which is not on this map. Cited by 542 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
542citing papers in PubMed, 3 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02796950 nacompletednot on this mapstarted 2016, after this paper: background citation

The Effect of Acipimox on GLP-1 Secretion in Healthy Subjects: a Pilot Study

TypeinterventionalSponsorUniversity of AarhusRan2016 to 2017Enrolled8ConditionsDiabetes Mellitus Type 2ArmsAcipimox
3 · Its place in the literature

Who cites it

542 citing papers in PubMed, 3 syntheses or guidelines pooled it, 948 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Cerebral fuels within the first week of life in very preterm infants: a cohort study.Archives of disease in childhood. Fetal and neonatal edition · 2026
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Lactate, Carbohydrate Restriction, and Cancer Metabolism.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Review

482 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John C NewmanGladstone Institutes and University of California San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA.
Eric VerdinGladstone Institutes and University of California San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA. Electronic address: everdin@gladstone.ucsf.edu.
University of California, San Francisco · US

Funding

RESEARCH TRAINING IN GERIATRIC MEDICINET32AG000212 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 1991 to 2026
$7.7M
Epigenetic regulation of healthspan and longevity by ketone bodiesK08AG048354 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEWMAN, JOHN C · 2014 to 2018
$972k
NIA NIH HHS K08 AG048354NIA NIH HHS T32 AG000212
6 · The paper itself

Abstract

Traditionally, the ketone body β-hydroxybutyrate (βOHB) has been looked upon as a carrier of energy from liver to peripheral tissues during fasting or exercise. However, βOHB also signals via extracellular receptors and acts as an endogenous inhibitor of histone deacetylases (HDACs). These recent findings support a model in which βOHB functions to link the environment, in this case the diet, and gene expression via chromatin modifications. We review the regulation and functions of ketone bodies, the relationship between ketone bodies and calorie restriction, and the implications of HDAC inhibition by the ketone body βOHB in the modulation of metabolism and in diseases of aging.

Indexed as

3-Hydroxybutyric AcidAgingAnimalsCaloric RestrictionHistone Deacetylase InhibitorsHistone DeacetylasesHumansKetone BodiesMonocarboxylic Acid TransportersSignal Transduction3-Hydroxybutyric AcidHistone Deacetylase InhibitorsHistone DeacetylasesKetone BodiesMonocarboxylic Acid Transportersacetylationcalorie restrictionepigeneticsHDAClongevity

Identifiers

PMID24140022
PMCPMC4176946
OpenAlexW2036551825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.